Cargando…

The Impact of HLA and KIR Ligand Mismatching on Unrelated Allogeneic Hematopoietic Stem Cell Transplantation in Korean Adult Patients

BACKGROUND: The impact of HLA and KIR ligand mismatching on the outcome of hematopoietic stem cell transplantation (HSCT) remains unclear. Previous reports have identified considerable ethnic differences in the impact of HLA and KIR ligand mismatches, as well as KIR ligand status, on HSCT; however,...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hyewon, Rho, Eun Youn, In, Ji Won, Kim, Inho, Yoon, Sung-Soo, Park, Seonyang, Shin, Sue, Park, Kyoung Un, Song, Eun Young
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Society for Laboratory Medicine 2015
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4272940/ https://www.ncbi.nlm.nih.gov/pubmed/25553290 http://dx.doi.org/10.3343/alm.2015.35.1.111

Ejemplares similares

The Presence of Anti-HLA Antibodies before and after Allogeneic Hematopoietic Stem Cells Transplantation from HLA-Mismatched Unrelated Donors
por: Koclega, Anna, et al.
Publicado: (2012)

The impact of HLA matching on unrelated donor hematopoietic stem cell transplantation in Korean children
por: Park, Meerim, et al.
Publicado: (2011)

HLA-C Incompatibilities in Allogeneic Unrelated Hematopoietic Stem Cell Transplantation
por: Tiercy, Jean-Marie
Publicado: (2014)

Association of FOXP3 Single Nucleotide Polymorphisms With Clinical Outcomes After Allogenic Hematopoietic Stem Cell Transplantation
por: Nam, Minjeong, et al.
Publicado: (2018)

False-Positive Reactions Against HLA Class II Molecules Detected in Luminex Single-Antigen Bead Assays
por: In, Ji Won, et al.
Publicado: (2014)

Clinical implications of HLA locus mismatching in unrelated donor hematopoietic cell transplantation: a meta-analysis
por: Tie, Ruxiu, et al.
Publicado: (2017)

Performance of LIFECODES HLA-DQB1 Typing Kit Using Luminex Platform in Koreans
por: Roh, Eun Youn, et al.
Publicado: (2015)

Impact of Previously Unrecognized HLA Mismatches Using Ultrahigh Resolution Typing in Unrelated Donor Hematopoietic Cell Transplantation
por: Mayor, Neema P., et al.
Publicado: (2021)

Integrating biological HLA-DPB1 mismatch models to predict survival after unrelated hematopoietic cell transplantation
por: Ruggeri, Annalisa, et al.
Publicado: (2022)

HLA-mismatched donor and high ferritin level showed poor clinical outcomes after allogeneic hematopoietic cell transplantation in patients with advanced myelofibrosis
por: Yoon, Jae-Ho, et al.
Publicado: (2020)

NK Cell Alloreactivity against KIR-Ligand-Mismatched HLA-Haploidentical Tissue Derived from HLA Haplotype-Homozygous iPSCs
por: Ichise, Hiroshi, et al.
Publicado: (2017)

Inhibitory KIR–HLA receptor–ligand mismatch in autologous haematopoietic stem cell transplantation for solid tumour and lymphoma
por: Leung, W, et al.
Publicado: (2007)

Outcomes with mismatched unrelated donor allogeneic hematopoietic stem cell transplantation in adults: A systematic review and meta-analysis
por: Mushtaq, Muhammad Umair, et al.
Publicado: (2022)

Influence of HLA-DPB1 mismatches on outcome after allogeneic hematopoietic stem cell transplantation
por: Hunziker, Mireille, et al.
Publicado: (2021)

Allogeneic hematopoietic cell transplantation with cord blood versus mismatched unrelated donor with post-transplant cyclophosphamide in acute myeloid leukemia
por: Dholaria, Bhagirathbhai, et al.
Publicado: (2021)

Protective Effect of HLA-DPB1 Mismatch Remains Valid in Reduced-Intensity Conditioning Unrelated Donor Hematopoietic Cell Transplantation
por: Malki, Monzr M. Al, et al.
Publicado: (2019)

Visilizumab with Tacrolimus and Methotrexate for Graft-Versus-Host Disease Prevention After Allogeneic Hematopoietic Cell Transplantation From Mismatched Unrelated Donors
por: Perez, Lia Elena, et al.
Publicado: (2016)

ADCC-Inducing Antibody Trastuzumab and Selection of KIR-HLA Ligand Mismatched Donors Enhance the NK Cell Anti-Breast Cancer Response
por: Ehlers, Femke A. I., et al.
Publicado: (2021)

Allogeneic hematopoietic cell transplantation for acute leukemia in first relapse or second remission
por: Lee, Je-Hwan, et al.
Publicado: (2010)

Association of HLA-DRB1 and -DQB1 Alleles with Susceptibility to IgA Nephropathy in Korean Patients
por: In, Ji Won, et al.
Publicado: (2022)

Unrelated HLA mismatched microtransplantation in a patient with refractory secondary acute myeloid leukemia
por: Punwani, Nathan, et al.
Publicado: (2018)

Characterization of Sera with Discordant Results from Reverse Sequence Screening for Syphilis
por: Lee, Kyunghoon, et al.
Publicado: (2013)

Donor-Recipient Matching for KIR Genotypes Reduces Chronic GVHD and Missing Inhibitory KIR Ligands Protect against Relapse after Myeloablative, HLA Matched Hematopoietic Cell Transplantation
por: Faridi, Rehan Mujeeb, et al.
Publicado: (2016)

Conjunctival Scarring in Trachoma Is Associated with the HLA-C Ligand of KIR and Is Exacerbated by Heterozygosity at KIR2DL2/KIR2DL3
por: Roberts, Chrissy h., et al.
Publicado: (2014)

The Effect of the COVID-19 Pandemic on Unrelated Allogeneic Hematopoietic Donor Collections and Safety
por: Parmar, Gaganvir, et al.
Publicado: (2023)

Killer Immunoglobulin-like Receptor (KIR) and HLA Genotypes Affect the Outcome of Allogeneic Kidney Transplantation
por: Nowak, Izabela, et al.
Publicado: (2012)

Association of iKIR-mismatch model and donor aKIRs with better outcome in haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia
por: Zhang, Yu, et al.
Publicado: (2023)

Comparison of the effect of DLI according to cell sources in relapsed AML after allogeneic stem cell transplantation
por: Park, Woochan, et al.
Publicado: (2023)

Association of Foxp3 Polymorphism With Allograft Outcome in Kidney Transplantation
por: Park, Hyewon, et al.
Publicado: (2017)

Hematopoietic Stem Cell Transplantation after Posttransplant Lymphoproliferative Disorder
por: Kim, Min Joo, et al.
Publicado: (2010)

KIR in Allogeneic Hematopoietic Stem Cell Transplantation: Need for a Unified Paradigm for Donor Selection
por: Dhuyser, Adèle, et al.
Publicado: (2022)

2660. Infection Complications Following Mismatched Allogeneic Hematopoietic Cell Transplantation
por: Ebisu, Yosuke, et al.
Publicado: (2019)

HLA-mismatched allogeneic adoptive immune therapy in severely immunosuppressed AIDS patients
por: Xu, Ruonan, et al.
Publicado: (2021)

The Benefits of the Post-Transplant Cyclophosphamide in Both Haploidentical and Mismatched Unrelated Donor Setting in Allogeneic Stem Cells Transplantation
por: Dybko, Jarosław, et al.
Publicado: (2023)

HLA-mismatched hematopoietic stem cell tranplantation for pediatric solid tumors
por: Pession, Andrea, et al.
Publicado: (2011)

KIR/HLA Interactions and Pathogen Immunity
por: Jamil, Khaleel M., et al.
Publicado: (2011)

Improved GRFS after posttransplant cyclophosphamide-based vs ATG-based HLA-mismatched unrelated donor transplant
por: Jimenez Jimenez, Antonio, et al.
Publicado: (2022)

Novel genetic variants associated with mortality after unrelated donor allogeneic hematopoietic cell transplantation
por: Hahn, Theresa, et al.
Publicado: (2021)

Comparison of Three Multiple Allergen Simultaneous Tests: RIDA Allergy Screen, MAST Optigen, and Polycheck Allergy
por: Han, Minje, et al.
Publicado: (2013)

Donor-specific anti-HLA antibodies in unrelated hematopoietic cell transplantation for non-malignant disorders
por: Woolfrey, Ann, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_g2r7qim0q4vou7qv2f08l34f79